Author

J. Wargo

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Assay:ChIP-seq· 1 Research Focus:clustering· 1 Approach:experimental assay· 1

Frequent Co-Authors

A. C. Frenk Oquendo· 1 shared A. Chaudhri· 1 shared A. D. Medrano· 1 shared A. Jazaeria· 1 shared A. Jhingran· 1 shared A. Klopp· 1 shared A. Lazar· 1 shared A. M. Alousi· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 12 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. C. Frenk Oquendo

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Enhancer Reprogramming in Melanoma Immune Checkpoint Therapy Resistance

M. Maitituoheti, A. Shi, M. Tang, L.-L. Ho, C. Terranova, K. Galani, E. Keung, C. Creasy, M. Wu, J. Chen, N. Chen, A. Singh, A. Chaudhri, N. Anvar, G. Tarantino, , K. Rai

The paper identifies enhancer-based biomarkers of resistance to anti-PD-1 therapy in melanoma and suggests enhancer blockade combined with ICB as a potential strategy to improve treatment responses.

bioRxiv · Aug 31, 2022 · PreprintCancer Biology

Diet-derived metabolites and mucus link the gut microbiome to fever after cytotoxic cancer treatment

Z. Schwabkey, D. Wiesnoski, C.-C. Chang, W.-B. Tsai, D. Pham, S. S. Ahmed, T. Hayase, M. R. Ortega Turrubiates, R. K. El-Himri, C. A. Sanchez, E. Hayase, A. C. Frenk Oquendo, T. Miyama, T. M. Halsey, B. E. Heckel, , E. J. Shpall

The paper links diet-derived metabolites and mucus to fever after cytotoxic cancer treatment by showing how Akkermansia muciniphila affects colonic mucus and inflammation.

bioRxiv · Sep 18, 2021Microbiology

Adaptive changes in the gut microbiome during standard-of-care chemoradiotherapy for gynecologic cancers

M. B. El Alam, T. T. Sims, R. Kouzy, G. Biegert, J. Abi Jaoude, T. Karpinets, K. Y. Court, X. Wu, A. D. Medrano, M. Mezzari, N. Ajami, T. Solley, M. Ahmed-Kaddar, L. Lin, L. Ramondetta, , L. Colbert

This study tracks gut microbiome diversity and composition changes in gynecologic cancer patients undergoing chemoradiotherapy, finding reduced diversity during treatment but partial recovery by week 12.

bioRxiv · Apr 10, 2020Cancer Biology